The global dry eye syndrome treatment market is driven by rise in prevalence of dry eye syndrome, increase in geriatric population, growth in awareness about the diagnosis and treatment of the disease, and increase in use of contact lenses. However, stringent regulatory process for drug approval and dearth of skilled ophthalmologists restrain the market growth. Conversely, increased government funding and presence of untapped market in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities for market growth during the forecast period.
Dry Eye Syndrome Treatment Market by Drug (Lubricant Eye Drops, Anti-inflammatory Drugs, and Autologous Serum Eye Drops), and Product (Liquid Drops, Gel, Liquid Wipes, and Eye Ointment) – Global Opportunity Analysis and Industry Forecast, 2022-2029
Download Sample: https://www.alliedmarketresearch.com/request-sample/2807
Key Benefits
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- Comprehensive analysis of all geographical regions is provided, to determine the prevailing opportunities.
- Key players are profiled and their strategies are analysed thoroughly to determine the competitive outlook of the global market.
- The report offers a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities.
- Exhaustive analysis of the global dry eye syndrome treatment market helps to determine the types of products used and the variants that are expected to gain prominence in the near future.
Dry Eye Syndrome Treatment Market Key Segments:
By Drug
- Lubricant Eye Drops
- Preservative-free Drops
- Oily Tear Eye Drops
- Anti-inflammatory Drugs
- Corticosteroid
- Tetracyclines Oral
- Autologous Serum Eye Drops
By Product
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Other
Request Customization: https://www.alliedmarketresearch.com/request-for-customization/2807
Key Market Players
- Novartis AG
- Allergan plc.
- Otsuka Holdings Co., Ltd.
- Santen Pharmaceutical Co., Ltd.
- Nicox S.A.
- Auven Therapeutics
- Akorn, Inc.
- Bausch & Lomb Incorporated
- Alimera Science
- GlaxoSmithKline plc.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2807
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.